Roth Capital Reiterates Buy on Legence, Maintains $120 Price Target

Benzinga Newsdesk www.benzinga.com Neutral 89.9%

Neg 0% Neu 89.9% Pos 0%

Roth Capital analyst Craig Irwin reiterates Legence (NASDAQ:LGN) with a Buy and maintains $120 price target.

Comments

No comments yet. Be the first!